About Eyenuk
Eyenuk is a company based in Los Angeles (United States) founded in 2010 by Kaushal Solanki.. Eyenuk has raised $38.05 million across 17 funding rounds from investors including NIH, HHS and AXA Investment Managers. Eyenuk offers products and services including EyeArt, Eyescreen Service, and Retinal Cameras. Eyenuk operates in a competitive market with competitors including AIdoc, AI Medical Service, eCential Robotics, Lantheus and Vista.ai, among others.
- Headquarter Los Angeles, United States
- Founders Kaushal Solanki
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Eyenuk, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$38.05 M (USD)
in 17 rounds
-
Latest Funding Round
$26 M (USD), Series A
Aug 23, 2022
-
Investors
NIH
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Eyenuk
Eyenuk offers a comprehensive portfolio of products and services, including EyeArt, Eyescreen Service, and Retinal Cameras. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Autonomous AI tool for detecting diabetic retinopathy from retinal images
Provides retinal image analysis for various eye diseases
Hardware for capturing retinal images in clinical settings
Unlock access to complete
Operations Team
1 people
Product Management Team
1 people
Strategic Team
1 people
Clinical Team
1 people
Unlock access to complete
Funding Insights of Eyenuk
Eyenuk has successfully raised a total of $38.05M across 17 strategic funding rounds. The most recent funding activity was a Series A round of $26 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 17
- Last Round Series A — $26.0M
-
First Round
First Round
(01 Jul 2011)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2022 | Amount | Series A - Eyenuk | Valuation | AXA Investment Managers | |
| Jul, 2021 | Amount | Series A - Eyenuk | Valuation | AXA Investment Managers |
|
| Oct, 2019 | Amount | Grant - Eyenuk | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Eyenuk
Eyenuk has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and AXA Investment Managers. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified alternative assets are managed through investment strategies.
|
Founded Year | Domain | Location | |
|
Venture capital investments are focused on health technology breakthroughs.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Eyenuk
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Eyenuk
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Eyenuk Comparisons
Competitors of Eyenuk
Eyenuk operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AIdoc, AI Medical Service, eCential Robotics, Lantheus and Vista.ai, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based single-screen system is provided to streamline medical imaging.
|
|
| domain | founded_year | HQ Location |
Provider of AI-based solution for diagnosis of cancer related lesions
|
|
| domain | founded_year | HQ Location |
Robotic surgery platform for bone procedures is developed.
|
|
| domain | founded_year | HQ Location |
Developer of diagnostic imaging agents and targeted therapeutics
|
|
| domain | founded_year | HQ Location |
AI-guided software is utilized to automate MRI exams for clinicians.
|
|
| domain | founded_year | HQ Location |
Provider of AI-based skin cancer monitoring and detecting device for patients and doctors
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Eyenuk
Frequently Asked Questions about Eyenuk
When was Eyenuk founded?
Eyenuk was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Where is Eyenuk located?
Eyenuk is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Who is the current CEO of Eyenuk?
Gaurav Agarwal is the current CEO of Eyenuk.
Is Eyenuk a funded company?
Eyenuk is a funded company, having raised a total of $38.05M across 17 funding rounds to date.
What does Eyenuk do?
Eyenuk was established in 2010 in Los Angeles, United States, within the health technology sector focused on ophthalmology. Automated analysis of retinal images is provided through machine learning to detect diabetic retinopathy lesions in fundus photographs via the EyeArt platform. Progression tracking is enabled by EyeMark, while EyeSeeAMD supports diagnosis of age-related macular degeneration. Mobile screening is facilitated by EyeApp, which integrates smartphones with compact imaging devices for on-site assessments.
Who are the top competitors of Eyenuk?
Eyenuk's top competitors include AIdoc, eCential Robotics and Vista.ai.
What products or services does Eyenuk offer?
Eyenuk offers EyeArt, Eyescreen Service, and Retinal Cameras.
Who are Eyenuk's investors?
Eyenuk has 7 investors. Key investors include NIH, HHS, AXA Investment Managers, T&W Medical A/S, and Kendall Capital Partners.